+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colcrys"

Gout - Opportunity Assessment and Forecast - Product Thumbnail Image

Gout - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 62 Pages
  • Global
From
Colcrys - API Insight, 2022 - Product Thumbnail Image

Colcrys - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Colcrys- Drug Insight, 2019 - Product Thumbnail Image

Colcrys- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Colcrys (colchicine) is a medication used to treat gout and other inflammatory conditions. It is a member of the Immune Disorders Drugs class, which includes medications that reduce inflammation and suppress the immune system. Colcrys works by blocking the production of certain proteins that cause inflammation. It is also used to prevent and treat attacks of gouty arthritis. Colcrys is available in both generic and brand-name forms. It is typically taken orally, but can also be administered intravenously. Common side effects include nausea, vomiting, and diarrhea. Colcrys is a widely used medication for treating gout and other inflammatory conditions. It is available in both generic and brand-name forms, and is typically taken orally. Some companies in the Colcrys market include Takeda Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more